BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1
520 results:

  • 1. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
    Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
    [No Abstract]    [Full Text] [Related]  

  • 2. A Study on Geographic Correlation between Indoor Radon Exposure and leukemia Incidence in Canada.
    Chen J
    Health Phys; 2024 May; 126(5):315-321. PubMed ID: 38526250
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Immune Reconstitution after BTKi Treatment in Chronic Lymphocytic leukemia].
    Wang YL; Tang PX; Chen KL; Guo GY; Long JL; Zou YQ; Liang HY; Xu ZS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):1-5. PubMed ID: 38387891
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Chronic Lymphocytic leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.
    Grants JM; May C; Bridgers J; Huang S; Gillis S; Meissner B; Boyle M; Ben-Neriah S; Hung S; Duns G; Hilton L; Gerrie AS; Marra M; Kridel R; Sabatini PJB; Steidl C; Scott DW; Karsan A
    Clin Chem; 2024 Jan; 70(1):273-284. PubMed ID: 38175592
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
    Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax.
    Jain N; Croner LJ; Allan JN; Siddiqi T; Tedeschi A; Badoux XC; Eckert K; Cheung LWK; Mukherjee A; Dean JP; Szafer-Glusman E; Seymour JF
    Clin Cancer Res; 2024 Feb; 30(3):498-505. PubMed ID: 37955424
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation.
    Brunner A; Thalhammer-Thurner GC; Willenbacher W; Haun M; Zelger BG; Willenbacher E
    Ann Hematol; 2024 Feb; 103(2):553-563. PubMed ID: 37951851
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Quaternary Benzophenanthridine Alkaloids Act as Smac Mimetics and Overcome Resistance to Apoptosis.
    Kulíšková P; Vašátková L; Slaninová I
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895085
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia.
    Zhang Y; Wu Q; Yuan B; Huang Y; Jiang L; Liu F; Yan P; Jiang Y; Ye J; Jiang X
    BMC Cancer; 2023 Oct; 23(1):1030. PubMed ID: 37875840
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL.
    Liang EC; Albittar A; Huang JJ; Hirayama AV; Kimble EL; Portuguese AJ; Chapuis A; Shadman M; Till BG; Cassaday RD; Milano F; Kiem HP; Riddell SR; Turtle CJ; Maloney DG; Gauthier J
    Blood Adv; 2023 Nov; 7(22):6990-7005. PubMed ID: 37774014
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study.
    Shao R; Zhang Y; He J; Huang F; Fan Z; Yang K; Xu Y; Xu N; Luo Y; Deng L; Zhang X; Chen J; Han M; Li X; Yu S; Liu H; Liang X; Luo X; Shi P; Wang Z; Jiang L; Zhou X; Lin R; Chen Y; Tu S; Sun J; Wang Y; Liu Q; Xuan L
    Signal Transduct Target Ther; 2023 Sep; 8(1):348. PubMed ID: 37704613
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Treatment Refractoriness in Chronic Lymphocytic leukemia: Old and New Molecular Biomarkers.
    Maher N; Mouhssine S; Matti BF; Alwan AF; Gaidano G
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373521
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial.
    Schrag D; Uno H; Rosovsky R; Rutherford C; Sanfilippo K; Villano JL; Drescher M; Jayaram N; Holmes C; Feldman L; Zattra O; Farrar-Muir H; Cronin C; Basch E; Weiss A; Connors JM;
    JAMA; 2023 Jun; 329(22):1924-1933. PubMed ID: 37266947
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Therapies for acute myeloid leukemia in patients ineligible for standard induction chemotherapy: a systematic review.
    Heuser M; Fernandez C; Hauch O; Klibanov OM; Chaudhary T; Rives V
    Future Oncol; 2023 Apr; 19(11):789-810. PubMed ID: 37170899
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A novel fluorescent nanoprobe for sensitive detection of 6-thioguanine in human serum based on Cu/Ag nanoclusters.
    Chen W; Hu D; Yang M; Zhu Y; Wu Y; Li X; Zhang J; Yang J; Huang Y; Xie J
    Anal Methods; 2023 May; 15(18):2270-2274. PubMed ID: 37129412
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid leukemia by Targeting XPO1/eIF4E/c-MYC Signaling.
    Long H; Hou Y; Li J; Song C; Ge Z
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047788
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. CD33 BiTE
    Marcinek A; Brauchle B; Rohrbacher L; Hänel G; Philipp N; Märkl F; Strzalkowski T; Lacher SM; Udiljak D; Spiekermann K; Theurich S; Kobold S; Kischel R; James JR; Bücklein VL; Subklewe M
    Cancer Immunol Immunother; 2023 Jul; 72(7):2499-2512. PubMed ID: 37041225
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.
    Vergara-Cadavid J; Johnson PC; Kim HT; Yi A; Sise ME; Leaf DE; Hanna PE; Ho VT; Cutler CS; Antin JH; Gooptu M; Kelkar AH; Wells SL; Nikiforow S; Koreth J; Romee R; Soiffer RJ; Shapiro RM; Gupta S
    Transplant Cell Ther; 2023 Jul; 29(7):455.e1-455.e9. PubMed ID: 37015320
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma.
    El Hussein S; Medeiros LJ; Lyapichev KA; Fang H; Jelloul FZ; Fiskus W; Chen J; Wei P; Schlette E; Xu J; Li S; Kanagal-Shamanna R; Yang H; Tang Z; Thakral B; Loghavi S; Jain N; Thompson PA; Ferrajoli A; Wierda WG; Jabbour E; Patel KP; Dabaja BS; Bhalla KN; Khoury JD
    Pathology; 2023 Jun; 55(4):514-524. PubMed ID: 36933995
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comparative effectiveness and safety of antibiotic prophylaxis during induction chemotherapy in children with acute leukaemia: a systematic review and meta-analysis.
    Yang M; Lu X; Xin L; Luo J; Diao S; Jia Z; Cheng G; Zeng L; Zhang L
    J Hosp Infect; 2023 Jun; 136():20-29. PubMed ID: 36921630
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 26.